PPA2 and neoplasm: Consistently, under long-term hypoxic conditions, decreased cell viability in rPPA2 K176E rescued group compared to that of rPPA2 WT also demonstrated that rPPA2 K176E effectively counteracted PPA2-deficiency induced hypoxia resistance of tumor cells (Fig. 6C).